Management of Umbilical Endometriosis
Surgical excision is the treatment of choice for umbilical endometriosis, providing both diagnostic confirmation and therapeutic benefit with a low risk of recurrence. 1
Diagnosis and Clinical Presentation
Umbilical endometriosis accounts for 0.5-1% of all extra-pelvic endometriosis cases and presents with characteristic features 1, 2:
- Brown to dark nodule in the umbilicus
- Cyclical pain during menstruation
- Umbilical swelling
- Catamenial bleeding from the umbilical lesion
Diagnosis should be based on clinical symptoms and confirmed by histopathological examination 3, 1
Imaging studies such as ultrasound and MRI can help assess the extent of the lesion and rule out multifocal involvement 1, 4
Treatment Algorithm
First-Line Management: Surgical Approach
Complete surgical excision with free margins is the gold standard treatment for umbilical endometriosis 1, 5, 2
Laparoscopically-assisted approach may be beneficial, especially for:
- Recurrent cases
- Cases with suspected intra-abdominal involvement
- More extensive disease 6
Surgical excision provides:
Second-Line/Adjunctive Management: Medical Therapy
Post-Treatment Follow-Up and Outcomes
Recurrence rates after surgical excision are relatively low, with anatomical recurrence reported in only 5.4% of cases 2
Symptom recurrence occurs in approximately 27% of patients, with a lower rate observed in those receiving post-operative hormonal therapy 2
Patient satisfaction rates following surgical treatment are high (83.8%), confirming surgical excision as the preferred approach 2
Important Considerations and Pitfalls
Umbilical endometriosis can be either primary (spontaneous) or secondary (following surgical procedures) 1, 5
Concomitant pelvic endometriosis is present in approximately 66% of umbilical endometriosis cases, warranting consideration of further evaluation 2
Superficial treatments (such as diathermocoagulation) should be avoided as they predispose patients to disease relapse 6
Post-operative hormonal therapy should be considered to reduce the risk of symptom recurrence 2
Long-term follow-up is recommended to monitor for potential recurrence 6, 2